23
Oct 2025
GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies
GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies.